Abstract
The goals of cancer prevention are to reduce the incidence, morbidity, and mortality due to cancer through the identification and elimination of precancerous lesions (termed intraepithelial neoplasias or IENs) and/or the early detection of minimally invasive cancers. Between 2001 and 2009, the USA saw an average 1.6 % annual reduction in the total number of cancer deaths (Howlader et al., 2012). While declining death rates have been seen for all racial and ethnic groups in the USA, there have been smaller reductions among women than men and smaller reductions in deaths among African Americans as compared to populations with a European heritage (Jemal et al., 2010). These reductions were primarily due to advances in and improved access to cancer detection and prevention efforts, resulting in less exposure to risk factors such as tobacco (Jemal et al., 2010). As a result, an estimated 767,100 cancer deaths have been averted over the past two decades in the USA (Jemal et al., 2010). These averted deaths are largely driven by reductions in lung cancer (reduction in tobacco use), stomach cancer (reduced H. pylori infections and improved food storage and preservation methods), breast cancer and colorectal cancer (due to improved screening and treatment modalities), cervical cancer (Pap testing and the HPV vaccine), as well as lymphoma, leukemia, and testicular cancer (due to new treatments). Unfortunately, other cancers have increased, such as liver cancer (increasing hepatitis C infections), esophageal cancer (associated with increasing obesity and gastric reflux disease), pancreatic cancer, and melanoma (due to sun exposure). Despite the recent reduction in incidence and mortality rates, cancer remains the second leading cause of mortality in the USA (responsible for over 580,000 deaths per year) (Siegel et al., 2013). For Americans from the age of 40–79, cancer is the leading cause of death (Siegel et al., 2013). Only at age 80 and older does heart disease surpass cancer. Therefore, it is extremely important that we continue to prioritize efforts in cancer prevention and control to reduce the impact of these diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
ACS (2008) American Cancer Society Cancer Facts & Figures 2008, Special Section, pp 22–42. Available at: http://www.cancer.org/acs/groups/content/@nho/documents/document/2008cafffinalsecuredpdf.pdf. Accessed 13 Feb 13
ACS (2013) American Cancer Society Facts and Figures, 2013. Available at: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf. Accessed 13 Feb 13
Alberts DS, Barakat RR et al (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 330(15):1029–1035
Alberts DS (1999) A unifying vision of cancer therapy for the 21st century. J Clin Oncol 17(11 Suppl):13–21
Alberts DS, Barakat RR et al (2004) Prevention of gynecologic malignancies. In: Gershenson DM, McGuire WP, Gore M, Quinn MA, Thomas G (eds) Gynecologic cancer: controversies in management. El Sevier Ltd, Philadelphia
Baron JA, Sandler RS, Bresalier RS, Lanas A, Morton DG, Riddell R, Iverson ER, Demets DL (2008) Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial. Lancet 372(9651):1756–1764
Brown JK, Byers T, Doyle C et al (2003) Nutrition and physical activity during and after cancer treatment. CA Cancer J Clin 53:268–291
Burton GW, Ingold KU (1984) Beta-carotene: an unusual type of lipid antioxidant. Science 224(4649):569–573
Chlebowski RT, Aiello E, McTiernan A (2002) Weight loss in breast cancer patient management. J Clin Oncol 20:1128–1143
Cline RJW, Hayes KM (2001) Consumer health information seeking on the internet: the state of the art. Health Educ Res 16(6):671–692
Davies AA, Davey Smith G, Harbord R et al (2006) Nutritional intervention and outcome in patients with cancer or preinvasive lesions: a systematic review. J Natl Cancer Inst 98:961–973
Fisher B, Costantino JP et al (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90(18):1371–1388
Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307(5):491–497
Freedman AN, Graubard BI, Rao SR et al (2003) Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention. J Natl Cancer Inst 95(7):526–532
George SM, Irwin ML, Smith AW, Neuhouser ML et al (2011) Postdiagnosis diet quality, the combination of diet quality and recreational physical activity, and prognosis after early-stage breast cancer. Cancer Causes Control 22(4):589–598
Giovannucci E (1999) The epidemiologic basis for nutritional influences on the cancer cell. In: Heber D, Blackburn GL, Go VLW (eds) Nutritional oncology. Academic, San Diego
Holmes MD, Chen WY, Feskanich D et al (2005) Physical activity and survival after breast cancer. JAMA 293:2479–2486
Howlader N, Noone AM, Krapcho M et al (eds) (2012) SEER cancer statistics review, 1975–2009, National Cancer Institute, Bethesda. http://seer.cancer.gov/csr/1975_2009_pops09/, based on November 2011 SEER data submission, posted to the SEER web site, Apr 2012
IOM (Institute of Medicine) (2002) Care without coverage: too little, too late. National Academy Press, Washington, DC
Jemal A, Ward E, Thun M (2010) Declining death rates reflect progress against cancer. PLoS One 15(3):e9584
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90
Jemal A, Simard EP, Dorrell C, Noone AM et al (2013) Annual report to the nation on the status of cancer, 1975–2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst 105(3):175–201
Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, McAfee T, Peto R (2013) 21st century hazards of smoking and benefits of cessation in the United States. N Engl J Med 368:341–350
Mackay J, Jemal A, Lee N et al (2006) The cancer atlas. The American Cancer Society, Atlanta
Martin AB, Lassman D, Washington B, Catlin A (2012) Growth in US health spending remained slow in 2010; health share of gross domestic product was unchanged from 2009). Health Aff 31(1):208–219
Meyerhard JA, Giovannucci EL, Holmes MD et al (2006) Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol 24:3527–3534
Nagle CM, Purdie DM, Webb PM et al (2003) Dietary influences on survival after ovarian cancer. Int J Cancer 106:264–269
Omenn GS, Goodman GE et al (1996) Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 88(21):1550–1559
O’Shaughnessy JA, Kelloff GJ et al (2002) Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development. Clin Cancer Res 8(2):314–346
Ornish D, Weidner G, Fair WR et al (2005) Intensive lifestyle changes may affect the progression of prostate cancer. J Urol 174:1065–1069
Rock CL, Deark-Wahnefried W (2002) Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol 20:3302–3316
Schmitz KH, Holtzman J, Courneye KS et al (2005) Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 14:1588–1595
Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63(1):11–30
Sporn MB (1976) Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res 36(7 PT 2):2699–2702
Squires D (2012) Explaining high health care spending in the United States: an international comparison of supply, utilization, prices and quality. The Commonwealth Fund. May 2012
Stevens GA, Singh GM, Lu Y et al (2012) National, regional and global trends in adult overweight and obesity prevalences. Popul Health Metr 10:22. doi:10.1186/1478-7954-10-22
Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM (2010) The global burden of cancer: priorities for prevention. Carcinogenesis 31(1):100–110
UICC (2010) Annual report 2009. Available at http://www.uicc.org/resources/annual-report-2009. Accessed 1 Feb 13
Vogel VG, Constantino VP et al (2006). Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial. JAMA 295(23):2727–2741
Wattenberg LW (1993) Prevention–therapy–basic science and the resolution of the cancer problem. Cancer Res 53(24):5890–5896
Wolin KY, Carson K, Coldiz GA (2010) Obesity and cancer. Oncologist 15(6):556–565
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Alberts, D.S., Hess, L.M. (2014). Introduction to Cancer Prevention. In: Alberts, D., Hess, L. (eds) Fundamentals of Cancer Prevention. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-38983-2_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-38983-2_1
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-38982-5
Online ISBN: 978-3-642-38983-2
eBook Packages: MedicineMedicine (R0)